EUFOREA treatment algorithm for allergic rhinitis

1 KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Allergy and Clinical Immunology Research Group, Leuven, Belgium; 2 University Hospitals Leuven, Department of Otorhinolaryngology, Leuven, Belgium; 3 University Hospital Ghent, Department of Otorhinolaryngology, Laboratory of Upper Airways Research, Ghent, Belgium; 4 Academic Medical Center, University of Amsterdam, Department of Otorhinolaryngology, Amsterdam, The Netherlands; 5 RNENT Hospital, Huntley Street, London, UK; 7 Upper Airways Research Laboratory, Dept of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium; 8 Division of ENT diseases, CLINTEC, Karolinska Institute, University of Stockholm, Sweden; 9 Sun Yat-sen University, International Airway Research Center, First Affiliated Hospital, Guangzhou, China; 10 Dept of Respiratory Medicine and Allergology, Skane University Hospital, Lund, Sweden; 11 Personalized Medicine Asthma and Allergy Clinic, Humanitas University and Research Hospital, Milan, Italy, and SANI-Severe Asthma Network Italy; 12 Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; 13 Ear, Nose, and Throat (ENT) Department, Flinders University, Bedford Park, South Australia, Australia; 141st Department of ORL, Head and Neck Surgery, Aristotle University, AHEPA Hospital, Thessaloniki, Greece; 15 European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium; 16 Dept of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden; 17 Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic; 18 Dept Clin Pharm and Pharmacol, Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; 19 Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London; 20 MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom; 21 Rhinology and Skull Base, Applied medical research center, University of New South Wales, Sydney, Australia; 22 Faculty of medicine and heath sciences, Macquarie University, Sydney, Australia; 23 Ear, Nose and Throat Department, Guys and St. Thomas Hospital, London, United Kingdom; 24 Department of Otorhinolaryngology Head and Neck surgery, Odense University Hospital, Denmark; 25 University of Southern Denmark, Odense, Denmark; 26 Center for Rhinology and Allergology, Wiesbaden, Germany; 27 Mainz University Allergy Center, Mainz, Germany; 28 Royal National Throat, Nose and Ear Hospital, UCLH, London, UK; 29 Optimum Patient Care, Cambridge, UK; 30 Observational and Pragmatic Research Institute, Singapore; 31 Academic Primary Care, University of Aberdeen, Aberdeen, UK; 32 Monash Health, Monash University, Melbourne, Australia; 33 Usher institute, University of Edinburgh, Edinburgh, UK; 34 The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Newport Isle of Wight, United Kingdom; 35 NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; 36 University of Southampton, Southampton, United Kingdom; 37 Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Skåne University Hospital, Malmö, Sweden; 38 Helsinki University Hospital, Helsinki, Finland; 39 Imperial College London, London, UK; 40 Royal Brompton and Harefield NHS Trust, London, UK; 41 Clinical Medicine, Griffith University, Southport, QLD, Australia; 42 Department of Otorhinolaryngology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; 43 Department of Otorhinolaryngology, Universitätsklinikum Düsseldorf, Dusseldorf, Germany; 44 Klinik für Pädiatrie m.S. Pneumologie und Immunologie, Charite, Berlin, Germany. Rhinology 58: 6, 618 622, 2020 https://doi.org/10.4193/Rhin20.246